{"alanine aminotransferase increased": 7.03, "aspartate aminotransferase increased": 6.53, "blood albumin decreased": 7.9, "blood alkaline phosphatase increased": 3.34, "blood bilirubin increased": 2.62, "blood lactate dehydrogenase increased": 2.37, "blood potassium decreased": 2.45, "blood potassium increased": 2.45, "bradycardia": 14.59, "cardiac failure": 2.81, "constipation": 5.67, "death": 8.3, "decreased appetite": 2.09, "disease progression": 28.03, "drug-induced liver injury": 4.29, "dysgeusia": 3.49, "dyspepsia": 2.91, "dysphagia": 3.06, "eating disorder": 3.37, "electrocardiogram qt prolonged": 13.66, "eye disorder": 2.07, "feeding disorder": 3.32, "fluid retention": 3.28, "gastrooesophageal reflux disease": 3.38, "general physical health deterioration": 2.09, "generalised oedema": 5.41, "haemoptysis": 2.98, "heart rate decreased": 4.79, "hepatic cytolysis": 3.07, "hepatic enzyme increased": 5.72, "hepatic failure": 4.56, "hepatic function abnormal": 8.36, "hepatitis": 3.2, "hepatotoxicity": 12.86, "hip fracture": 2.44, "hypertransaminasaemia": 6.02, "interstitial lung disease": 5.45, "liver disorder": 3.77, "liver function test abnormal": 3.17, "liver function test increased": 7.49, "liver injury": 5.1, "lung adenocarcinoma": 36.95, "lung cancer metastatic": 23.26, "lung disorder": 2.12, "lung neoplasm malignant": 102.67, "neoplasm malignant": 10.21, "neoplasm progression": 48.12, "neutropenia": 2.29, "non-small cell lung cancer": 65.48, "non-small cell lung cancer metastatic": 102.77, "odynophagia": 2.96, "oedema": 7.05, "oedema peripheral": 8.18, "oesophageal pain": 11.54, "oesophageal ulcer": 56.58, "oesophagitis": 21.53, "pericardial effusion": 6.08, "peripheral swelling": 2.07, "photopsia": 24.78, "pleural effusion": 7.53, "pneumonia": 4.64, "pneumonitis": 9.21, "pneumothorax": 2.35, "product use in unapproved indication": 6.32, "protein total decreased": 11.98, "pulmonary embolism": 2.87, "pulmonary oedema": 5.57, "pulmonary thrombosis": 4.56, "renal abscess": 68.93, "renal cyst": 23.53, "renal impairment": 3.96, "respiratory failure": 5.05, "second primary malignancy": 10.3, "sinus bradycardia": 12.88, "taste disorder": 6.33, "thrombosis": 2.24, "transaminases increased": 5.92, "visual impairment": 5.14, "vitreous floaters": 5.26, "vomiting": 2.08}